MistraPharma proposes new centre for drugs and the environment

MistraPharma has studied how pharmaceutical substances in low doses affect marine and freshwater ecosystems. It has also investigated the risks of antibiotic resistance arising from drugs in the environment. At a final conference in October, researchers from the programme discussed how its findings should be put to use by decision-makers. One suggestion was a new centre for drugs and the environment, based at the Swedish Medical Products Agency.

‘Being in charge of this leading-edge research has been an exciting task. Sweden is in the front line of research on pharmaceutical substances and aquatic organisms,’ says MistraPharma’s programme director, Christina Rudén.